ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
1-Year Return
169.78%
This Quarter Return
+23.75%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$281M
AUM Growth
+$47.4M
(+20%)
Cap. Flow
+$20.8M
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
60.27%
Holding
52
New
15
Increased
6
Reduced
10
Closed
6
Top Buys
| 1 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$44.9M |
| 2 |
BLU
BELLUS Health Inc.
BLU
|
$12.3M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$5.55M |
| 4 |
GH Research
GHRS
|
$5.37M |
| 5 |
Olema Pharmaceuticals
OLMA
|
$4.15M |
Top Sells
| 1 |
Celldex Therapeutics
CLDX
|
$35.1M |
| 2 |
Fulcrum Therapeutics
FULC
|
$7.94M |
| 3 |
ESSA Pharma
EPIX
|
$6.65M |
| 4 |
Aligos Therapeutics
ALGS
|
$4.37M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$3.78M |
Sector Composition
| 1 | Healthcare | 94.48% |
| 2 | Financials | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
ESSA Pharma
EPIX
$11M
| – | – |
-232,896
| Closed | -$6.65M |
|